- Supported exchanges /
- ST /
- PROGEN.ST
Prostatype Genomics AB (PROGEN ST) stock market data APIs
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company's test is based on database containing prostate cancer patients, as well as provides decision support for patients and doctors when making a treatment decision. Prostatype Genomics AB (publ) was incorporated in 2007 and is based in Solna, Sweden.
Prostatype Genomics AB Financial Data Overview
| 8.28 | |
| 8.14 | |
| - | |
| 7.93 | |
| 7.73 | |
| 5.1667-74.6819 | |
| 40 415 K | |
| 5 148 K | |
| 4 115 K | |
| -0.08 | |
| 0.692 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Prostatype Genomics AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 4 115 K
- EBITDA -39 045 532
- Earnings Per Share -93.94
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Prostatype Genomics AB Earnings via APIs
- Latest Release 2023-08-17
- EPS/Forecast -0.1
Get Prostatype Genomics AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
